Your browser doesn't support javascript.
loading
The emerging emetogenicity of trifluridine/tipiracil (TAS­102) from patient self-reporting: a multicenter, prospective, observational study.
Fujii, Hironori; Tsuchiya, Masami; Watanabe, Daichi; Otsuka, Ryo; Hirate, Daisuke; Takahashi, Katsuyuki; Go, Makiko; Kudo, Toshihiro; Shimomura, Kazuhiro; Ando, Yosuke; Tani, Shinya; Takahashi, Takao; Hayashi, Katsuhisa; Chin, Miki; Matsunami, Naomi; Takahashi, Masaya; Hasegawa, Akiko; Uchida, Takashi; Hashimoto, Hironobu; Kubo, Akiko; Matsuhashi, Nobuhisa; Suzuki, Akio; Nishimura, Junichi; Inui, Naoki; Iihara, Hirotoshi.
Afiliación
  • Fujii H; Department of Pharmacy, Gifu University Hospital, Gifu, Japan.
  • Tsuchiya M; Department of Pharmacy, Miyagi Cancer Center, Miyagi, Japan.
  • Watanabe D; Department of Pharmacy, Gifu University Hospital, Gifu, Japan.
  • Otsuka R; Innovative and Clinical Research Promotion Center, Gifu University Hospital, Gifu, Japan.
  • Hirate D; Department of Pharmacy, National Cancer Center Hospital, Tokyo, Japan.
  • Takahashi K; Department of Pharmacy, Teine Keijinkai Hospital, Hokkaido, Japan.
  • Go M; Department of Pharmacy, Osaka City University Hospital, Osaka, Japan.
  • Kudo T; Department of Pharmacy, Ogaki Municipal Hospital, Gifu, Japan.
  • Shimomura K; Department of Medical Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Ando Y; Department of Pharmacy, Aichi Cancer Center Hospital, Aichi, Japan.
  • Tani S; Department of Pharmacotherapeutics and Informatics, Fujita Health University, Aichi, Japan.
  • Takahashi T; First Department of Medicine, Hamamatsu University School of Medicine, Shizuoka, Japan.
  • Hayashi K; Department of Gastroenterological Surgery, Pediatric Surgery, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Chin M; Department of Surgery, Seino Kosei Hospital, Gifu Seino Medical Center, Gifu, Japan.
  • Matsunami N; Department of Pharmacy, Miyagi Cancer Center, Miyagi, Japan.
  • Takahashi M; Department of Pharmacy, National Cancer Center Hospital, Tokyo, Japan.
  • Hasegawa A; Department of Pharmacy, Teine Keijinkai Hospital, Hokkaido, Japan.
  • Uchida T; Department of Pharmacy, Osaka City University Hospital, Osaka, Japan.
  • Hashimoto H; Department of Medical Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Kubo A; Department of Pharmacy, Miyagi Cancer Center, Miyagi, Japan.
  • Matsuhashi N; Department of Pharmacy, National Cancer Center Hospital, Tokyo, Japan.
  • Suzuki A; Department of Pharmacy, National Cancer Center Hospital, Tokyo, Japan.
  • Nishimura J; Department of Gastroenterological Surgery, Pediatric Surgery, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Inui N; Department of Pharmacy, Gifu University Hospital, Gifu, Japan.
  • Iihara H; Laboratory of Advanced Medical Pharmacy, Gifu Pharmaceutical University, Gifu, Japan.
Support Care Cancer ; 32(5): 291, 2024 Apr 17.
Article en En | MEDLINE | ID: mdl-38630197

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirrolidinas / Timina / Neoplasias Colorrectales / Antieméticos Límite: Humans Idioma: En Revista: Support Care Cancer Asunto de la revista: NEOPLASIAS / SERVICOS DE SAUDE Año: 2024 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pirrolidinas / Timina / Neoplasias Colorrectales / Antieméticos Límite: Humans Idioma: En Revista: Support Care Cancer Asunto de la revista: NEOPLASIAS / SERVICOS DE SAUDE Año: 2024 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Alemania